RE:NO FDA APPROVAL ON ONE SIDE OF HEARTThey started, historically, with the right ventricle because they were interested in diagnosing pediatric and newborn conditions. Most congenital defects and newborn heart conditions involve the right ventricle. They did well clinically with that application, but it's a relatively specialized market if you're looking at the business model..
The clinical successfulness of that application and the business need to expand their sales base led to adding modelling of the Atria and left ventrical. They've work on the technology for that for a while now and the Health Canada approval was for the full heart application. With the full heart technology, they can sell to pretty every hospital and cardiac clinic in Canada which is a big new sales base. They are also allowed to sell in a number of other countries. They have CE Mark and FDA for the RV technolgy and are working on CFDA (Chinese) for the full heart through their partner. One place they can sell already is Hong Kong and that ties in with Chinese plans.